Authors/Disclosures
|
Rafael P. Dias-Carneiro, MD
(Private Clinic)
|
No disclosure on file |
|
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN
(University of Brasilia – School of Medicine)
|
Dr. Von Glehn Silva has nothing to disclose. |
|
Laura Popper, MD
(Mapi Pharma Ltd.)
|
Dr. Popper has received personal compensation for serving as an employee of Mapi Pharma. |
|
|
No disclosure on file |
|
Satoshi Yoshimura, PhD
(Kyushu University)
|
No disclosure on file |
|
Robert Altman, MD
(Jewish General Hospital)
|
Dr. Altman has nothing to disclose. |
|
|
No disclosure on file |
|
Alfredo Damasceno, MD
|
No disclosure on file |
|
Benito P. Damasceno, MD, PhD
(Neurology Department, Medical School, State University of Campinas (UNICAMP))
|
No disclosure on file |
|
|
No disclosure on file |
|
Charles Tilbery, MD
|
No disclosure on file |
|
Alla Shifrin, MD
(Rambam Medical Center)
|
Dr. Shifrin has nothing to disclose. |
|
|
No disclosure on file |
|
Ron E. Milo, MD, FAAN
(Barzilai Medical Center)
|
Dr. Milo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck KGaA . Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Milo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brystol-Myers-Squibb . Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neopharm. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Milo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystol-Myers-Squibb. |
|
Carlos Otavio Brandao, MD, PhD
(Neurolife)
|
No disclosure on file |